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INTRODUCTION: The skin is the largest organ 
of mammals. The loss of skin integrity may induce 
important dysfunctions or even death. For 
superficial wounds, the endogenous healing 
mechanisms in combination with traditional 
wound care are sufficient to achieve functional 
repair. In contrast, in larger wounds, like third and 
fourth degree burns, chronic wound or deep ulcers 
it is difficult to obtain the restitutio ad integrum 
and fibrosis and/or scar tissue develops1,2. The aim 
of this study was to verify the efficacy of 
conventional and innovative topic treatments on 
skin regeneration, induced experimentally in 
sheep. To achieve this goal different types of 
investigations (clinical, molecular, histological, 
immunohistochemical) were performed. 
METHODS: Six skin lesions (4x4cm) were 
surgically created on the back of six healthy adult 
sheep; every single wound was destined, in a 
randomized way, to one of the following 
treatments: Acemannan gel, Manuka Honey, 
hyaluronic acid, Plasma3 (ionized gas), allogeneic 
mesenchymal stem cells isolated from peripheral 
blood (PB-MSCs). The sixth wound was the 
placebo. Biopsies were collected with a surgical 
punch (0,6x0,6 cm) at time T0, T15 and T40 days.  
Lesions were clinically evaluated considering the 
presence and color of wound fluid, the state of 
hydration, the wound surface/surroundings and 
other parameters. Histological examinations 
considered crust formation, re-epithelization and 
epidermal thickness, dermis edema, extension of 
granulation tissue, acute and chronic 
inflammation. Immunohistochemistry for 
evaluation of inflammation, vascularization and 
cell proliferation was performed using CD3, 
CD20, MHCII, von Willebrand factor (vWF) and 
KI67 antibodies. Furthermore, Real time-PCR 
investigated genes as Vascular endothelial growth 
factors (VEGF), Transforming growth factor beta 
1(TGFβ1), Vimentin (VIM), Collagen 1α1 
(Col1α1) and hair Keratin (hKER).  
RESULTS: Clinically, the lesions treated with 
plasma healed more rapidly respect to other 
treatments and a reduced bacterial load was 
observed. At T7 wounds treated with stem cells 
and plasma were less macerated than lesions 
treated with other therapies. At T15 the wounds 
treated with hyaluronic acid showed a normal state 
of hydration while lesions treated with Manuka 
Honey exhibited a normal hydration from the third 
week only (Acemannan gel at fourth week). From 
the second week onwards all wounds did not show 
presence of fluid and exhibited a dry and clean 
secondary layer. All lesions, excluded wounds 
treated with acemannan gel, presented a red 
(hyaluronic acid and plasma) and dark red 
(Manuka Honey, PB-MSCs) granulation tissue 
starting from the first week. Molecular analysis 
showed a correspondence between clinical and 
molecular/histologic results. For instance, VEGF 
mRNA expression confirms angiogenetic events 
observed at histological level while TGF-β, CD3 
and CD20 mRNA/protein expression indicated the 
presence/absence of inflammation in the used 
treatments.         
DISCUSSION & CONCLUSIONS: Innovative 
therapies led to surprising results regarding 
regeneration of mammalian skin. Indeed, on the 
basis of clinical analysis, wounds treated with 
plasma and MSC healed more rapidly. Further 
examinations are ongoing in order to elucidate 
possible mechanisms explaining these differences. 
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